Carregant...
The place of ARBs in heart failure therapy: is aldosterone suppression the key?
Since the launch of the first orally available angiotensin II (AngII) type 1 receptor (AT(1)R) blocker (ARB) losartan (Cozaar) in the late 1990s, the class of ARBs (or ‘sartans’, short for Angiotensin-RecepTor-ANtagonistS) quickly expanded to include candesartan, eprosartan, irbesartan, valsartan, t...
Guardat en:
| Publicat a: | Ther Adv Cardiovasc Dis |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
SAGE Publications
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6691655/ https://ncbi.nlm.nih.gov/pubmed/31401939 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1753944719868134 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|